APOA1 and metabolic dysfunction-associated steatotic liver disease: ApoA1 is the major apolipoprotein in HDL, which plays an important role in fatty acid metabolism (Yanai et al., 2015), thus ApoA1 can influence NAFLD by regulating the accumulation of liver triglyceride intake in the diet (Choe et al., 2013).